Systemic and Local Hormone Therapy for Endometrial Hyperplasia and Early Adenocarcinoma

Abstract

Hormone therapy has varied response rates among women with endometrial hyperplasia or cancer who do not undergo surgery. Close patient monitoring remains paramount given the high recurrence and high percentage of patients who will not respond.